What are the requirements for a medication to be an orphan drug?
According to the US Food and Drug Administration (FDA), an orphan drug is defined as one “intended for the treatment, prevention or diagnosis of a rare disease or condition, which is one that affects less than 200,000 persons in the US” (which equates to approximately 6 cases per 10,000 population) “or meets cost …
What diseases do orphan drugs treat?
List of FDA Orphan Drugs
- Acquired hemophilia A.
- Acral lentiginous melanoma.
- Acromegaly.
- Acute intermittent porphyria.
- Acute lymphoblastic leukemia.
- Acute myeloid leukemia.
- Acute promyelocytic leukemia.
- Adenosine deaminase deficiency.
When do you apply for orphan drug designation?
In fact, the orphan application can be filed anytime in the drug development process before NDA/BLA submission, even prior to IND filing. Not only can there be multiple orphan designations per indication; more than one sponsor can receive an orphan designation for the same drug/indication.
What is orphan drug status?
A status given to certain drugs called orphan drugs, which show promise in the treatment, prevention, or diagnosis of orphan diseases. An orphan disease is a rare disease or condition that affects fewer than 200,000 people in the United States.
What is orphan drug give example?
Developing a drug intended to treat a rare disease does not allow the recovery of the capital invested for its research. Orphan drugs may be defined as : Drugs that are not developed by the pharmaceutical industry for economic reasons but which respond to public health need.
How long does orphan drug designation last?
Orphan drug status (designated by the FDA) gives a company exclusive marketing rights for a seven-year period, along with other benefits to recoup the costs of researching and developing drugs to treat rare diseases.
What is rare disease designation?
What is a rare disease? The Orphan Drug Act defines a rare disease as a disease or condition that affects less than 200,000 people in the United States.